Transglutaminase inhibitors attenuate vascular calcification in a preclinical model

OBJECTIVE: In vitro, transglutaminase 2 (TG2)-mediated activation of the β-catenin signaling pathway is central in warfarin-induced calcification, warranting inquiry into the importance of this signaling axis as a target for preventive therapy of vascular calcification in vivo. METHODS AND RESULTS:...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Beazley, Kelly E., Banyard, Derek, Lima, Florence, Deasey, Stephanie C., Nurminsky, Dmitry I., Konoplyannikov, Mikhail, Nurminskaya, Maria V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3544469/
https://ncbi.nlm.nih.gov/pubmed/23117658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.112.300260
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak